Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
110
Presentation to Include Preliminary Data from GeoVax’s Cancer Vaccine Program GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that its Chief...
Last modified on Continue reading
233
Continued Success and Progress in Vaccine Development Programs for Zika, HIV, Lassa Fever, Ebola, Malaria, Hepatitis B and Cancer GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Last modified on Continue reading
392
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with The Scripps Research Institute (TSRI) in La Jolla,...
Last modified on Continue reading
422
Single-Dose Vaccine Conferred 100% Protection in Lethal Challenge Model GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today a significant step forward...
Last modified on Continue reading
637
Supports Advanced Preclinical Testing in Preparation for Human Clinical Trials GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines, announced today that the...
Last modified on Continue reading